Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

BUTICAPS

BUTABARBITAL SODIUM

Standard Dose
15MG
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview BUTICAPS is listed in Drugs@FDA under application 085381 (ANDA).

Marketing status: Discontinued Active ingredient BUTABARBITAL SODIUM Form and strength CAPSULE;ORAL - 15MG Sponsor MEDPOINTE PHARM HLC Submission history Latest submission status date: 1978-04-11 00:00:00.

Structured Monograph

Clinical summary

Approval overview BUTICAPS is listed in Drugs@FDA under application 085381 (ANDA). Marketing status: Discontinued Active ingredient BUTABARBITAL SODIUM Form and strength CAPSULE;ORAL - 15MG Sponsor MEDPOINTE PHARM HLC Submission history Latest submission status date: 1978-04-11 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.
BUTICAPS (BUTABARBITAL SODIUM) | Drug Monograph | MedicHelpline